Kotsopoulos noted that BRCA carriers have a substantially increased lifetime risk of breast and ovarian cancer. Management of ...

However, many women with BRCA mutations perceive MHT as unsafe, due to concerns about their already elevated breast cancer risk. Joanne Kotsopoulos, a scientist at the Women’s College Hospital ...

Cirtuvivint is a selective pan-CLK, pan-DYRK inhibitor that modulates alternative RNA splicing, including transcripts involved in oncogenic pathways. Preclinical studies have shown that CLK/DYRK ...

Use of MHT following menopause is not associated with an increased risk for breast cancer among BRCA1 and BRCA2 carriers.

An affordable new BRCA gene test has hit the market, but who should take it? — -- A new genetic testing kit that hits the market today is the most affordable, and arguably one of the simplest, ...

Using menopausal hormone therapy (MHT) was not associated with an increased risk of breast cancer in women with inherited ...

The use of hormone replacement therapy (HRT) does not have an adverse effect on breast cancer risk according to results from ...

The announcement by Health Secretary Wes Streeting that the NHS Jewish BRCA Testing Programme is to be restarted next year is welcome news. Most importantly, it will come as a great relief for anyone ...

It might feel like your world stops after receiving a diagnosis of breast or ovarian cancer. Even in that mental and emotional fog, there are several next steps to consider. Coming up with a treatment ...

This study came out of a multi-institutional collaboration called the BRCA BCY group, which is an international group of ...

We tend to think of BRCA genetic mutations as a major risk for breast cancer—and they are. But these mutations—present on genes that can normally help suppress tumor activity via producing proteins ...

Lindsay Avner gave birth to her daughter last month. Lindsay Avner used IVF to ensure her daughter would not carry a BRCA gene mutation. She's seen here with her husband and step-children. Laura ...